Skip to content
Trial Eligibility
Menu

BRE-13: Mediterranean Diet

NCT07869355

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Explore the effect of MedDiet vs. Usual Diet on circulating and breast tumor fatty acid profiles. The investigators aim to examine impact on tumor biology in newly diagnosed participants.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Dietary Assessment
  • Dietary and Lifestyle Behaviour Change
  • Dietary Behavior
  • Metabolic Health
  • Obesity
  • Lifestyle Modification
  • Metabolic Syndrome Risk

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 80 years
Sex
Female
Healthy volunteers
Not accepted
Sponsor
University of Illinois Chicago
Last updated on ClinicalTrials.gov
November 16, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Illinois · 1

  • University of Illinois at Chicago Campus · Chicago, IL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.